Management Policies
Intervention
mid 2007 mid 2008 July 2009
HIV:
People on ARV treatment
1.1 million 1.75 m 2.3 m
TB:
People treated under DOTS
2.8 million 3,9 m 5.4 m
Malaria:
Insecticide-treated nets 30 million 59 m 88 m
distributed
Malaria treatments .. .. 74 m
Malaria
29%
HIV/AIDS
57%
TB
14%
100% = US$ 15.9 billion
Percentages of total funds approved by the
Board, including Phase 2 & RCC
Data from
2006-2007
Quality-assured products
Lowest possible price
National laws and international
agreements
Conduct procurement processes in
a transparent and competitive
manner
Second-line TB medicines :
procured through the Green Light Committee
Amitriptyline
Meclizine, dimenhydrinate, prochlorperazine, promethazine
Ibuprofen, paracetamol, codeine
Hydrocortisone cream, calamine, caladryl lotions
Antihistamines (diphenhydramine, chlorpheniramine, reactions
dimenhydrinate), corticosteroids (prednisone, dexamethasone)
Inhaled beta-agonists (albuterol, etc.), inhaled corticosteroids
(beclomethasone, etc.), oral steroids (prednisone), injectable
steroids (dexamethasone, methylprednisolone)
Levothyroxine
Potassium and magnesium replacement
Antiretrovirals
Medicines to treat HIV/AIDS related conditions:
Mainly those listed in WHO-PQ EOI
Some additions depending on country:
Methadone and buprenorphine
Metronizadole
Amoxicillin, erythromycin, cloxacillin
WHO PQ EOI
ACTs